Vireo Growth (VREOF) Cash & Equivalents Growth (5y) (2025 - 2026)

Vireo Growth (VREOF) Cash & Equivalents Growth (5y) (2025 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Haleon	43.87 Bn	42.91 Bn	-
2	Teva Pharmaceutical Industries	43.00 Bn	39.35 Bn	2.15 Bn
3	Zoetis	31.59 Bn	29.92 Bn	1.05 Bn
4	Takeda Pharmaceutical	28.63 Bn	22.83 Bn	5.10 Bn
5	United Therapeutics	22.15 Bn	19.49 Bn	683.80 Mn
6	Viatris	18.74 Bn	17.85 Bn	1.46 Bn
7	Neurocrine Biosciences	15.55 Bn	15.16 Bn	935.80 Mn
8	Elanco Animal Health	11.75 Bn	11.22 Bn	798.00 Mn
9	Dr Reddys Laboratories	10.12 Bn	9.96 Bn	-
10	Vireo Growth	491.44 Mn	349.14 Mn	95.30 Mn

Download Data